The potential of additive manufacturing and complex concentrated alloys, along with their chemical and biochemical functionalization.
CoCoA-Bio is an innovative project that combines a novel concept of material solutions (complex concentrated alloys or multi-principal element alloys) for IMDs (Implantable Metallic Devices). This multidisciplinary project bridges fundamental research in pure scientific topics of physical metallurgy and materials chemistry with applied research in medical device development, offering an innovative solution for the future of medicine. The CoCoA-Bio consortium leverages a multidisciplinary expertise ranging from metallurgy (physical & materials chemistry) to peptide and protein chemistry, as well as cellular engineering, with applications in biomedical sciences (from lab to bedside). It brings together high-level scientists from renowned universities and research centers, clinical implantology experts, and industrial partners (SMEs) involved in the formulation and additive manufacturing of medical devices. The current consortium is built on two complementary main pillars: (1) manufacturing and physical metallurgy, and (2) surface chemistry and bioengineering.
The project architecture has been designed to identify multiple alloy candidates (or compositions) within the same family for the intended application, and then converge towards the most promising solution by using appropriate tools for each development stage (design, manufacturing, post-processing, and characterization). The selected material solution is further optimized in terms of surface properties (roughness, shape) and tested in vitro under various biological environments (corrosion, cytocompatibility, bioactivity), depending on the type of implantation targeted (jaw, femur, tibia, etc.).
The proposed material solution is based on the innovative concept of complex composition alloy metallurgy (multi-principal element alloys) produced via additive manufacturing (laser powder bed fusion technology). The objective is to create a synergy between mechanical properties (Young’s modulus, mechanical strength, fatigue lifespan) and chemical and biochemical functionalization. The selected alloys are primarily composed of Ti, Nb, Zr, Mo, Ta, and bioinert chemical elements.
A Public Health Challenge : With the aging population in modern societies and the increasing risk of bone diseases or injuries, developing durable implant materials is a major public health concern. It is crucial to design advanced structural materials capable of extending the lifespan of implants beyond the current limit of 10 to 15 years, thus delaying the need for revision surgery as much as possible. Implantable Metallic Devices (IMDs) based on multi-principal element alloys (MPEAs) and fabricated via additive manufacturing (AM or 3D printing) have the potential to revolutionize healthcare. By combining these two innovative concepts (MPEA and AM), the composition and morphology of IMDs can be functionally adapted to address medical conditions, anatomical structures, patient age, and sex, laying the foundation for personalized treatments. Our long-term vision is to create an inclusive environment where IMDs are safely used with minimal long-term effects, providing effective and safe treatments for various medical conditions.
The proposed research and development efforts also include the chemical and biochemical functionalization of IMD surfaces to ensure the best clinical outcomes. Developing implants from these new material solutions that are easier to use, less invasive, and more cost-effective than current alternatives is a critical societal challenge and remains an ongoing technological hurdle.
MPEAs represent a new class of materials that offer unique properties, such as high strength and corrosion resistance. Consequently, they are increasingly used in the medical industry for various applications. The CoCoA-Bioproject explores the use of MPEAs for IMDs and their potential for technological breakthroughs due to their distinctive properties.MPEAs are highly durable and corrosion-resistant, making them ideal for medical applications. Furthermore, they exhibit a high strength-to-weight ratio, making them lightweight while maintaining superior strength and durability, which is particularly advantageous for medical device design. By adjusting alloy composition, optimized materials can be tailored for specific applications. For example, their Young’s modulus can be reduced to values close to that of bones (around 20-30 GPa) without compromising their elastic limit, thus reducing the risk of osteoporosis near the implant. Although Ti6Al4V remains widely used in the field, Ti-Zr-Nb alloys hold great promise, particularly if their mechanical properties can be improved. The HEA/MPEA concept could fulfill these expectations and drive significant advancements in implantable medical technology.
- The combination of additive manufacturing and the HEA/MPEA concept to produce custom-made implants with improved performance and longevity.
- The establishment of a multidisciplinary network of experts (physical metallurgy, materials science, peptide chemistry, cellular engineering, implantology, European medical device regulations).
- The deployment of a material solution based on the original concept of complex composition alloy metallurgy (multi-principal element alloys) composed of Ti, Nb, Zr, Mo, Ta (bio-inert chemical elements), produced via additive manufacturing (laser powder bed fusion technology), optimizing both mechanical properties (Young’s modulus, mechanical strength, fatigue lifespan, etc.).
The project seeks to answer the following questions: (a) Do the bulk materials obtained after additive manufacturing exhibit superior mechanical properties (elastic modulus, mechanical strength, fatigue lifespan) compared to existing solutions? (b) Are the resulting materials biocompatible, considering their constituent chemical elements? (c) If so, what is the level of chemical and biochemical functionalization compared to existing materials?